Medical Devices: Page 129


  • Dive Awards

    Disruption of the Year: EU MDR notified bodies shortage

    The new European Union Medical Device Regulation requires more devices to undergo notified body review than ever before. But there are worries there aren't enough notified bodies to handle the workload.

    By Dana Elfin • Dec. 9, 2019
  • Image attribution tooltip
    Kendall Davis/MedTech Dive, original photos courtesy of Abbott and Dexcom
    Image attribution tooltip
    Dive Awards

    Rivalry of the Year: Abbott and Dexcom's race to dominate CGM

    As tech-led diabetes management becomes more mainstream, the "lead horses" in continuous glucose monitor manufacturing have committed to multiplying production capacity and are eyeing expansion into new populations.

    By Maria Rachal • Dec. 9, 2019
  • Close up of hand touching smartwatch with health app on the screen. Explore the Trendlineâž”
    Image attribution tooltip
    Sitthiphong via Getty Images
    Image attribution tooltip
    Trendline

    Medical device industry continues to turn to AI

    While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

    By MedTech Dive staff
  • Image attribution tooltip
    Photo courtesy of Stryker
    Image attribution tooltip
    Dive Awards

    Executive of the Year: Kevin Lobo, Stryker

    Stryker's year was shaped by two of the biggest fruits of the newly minted AdvaMed chairman's dealmaking: expansion of the Mako robot and the addition of Wright Medical.

    By Maria Rachal • Dec. 9, 2019
  • Dive Awards

    Company of the Year: Edwards Lifesciences

    With a laser focus on structural heart care, the company's transcatheter aortic valve replacement technology proved superior and gained approval among patients once considered better candidates for open heart surgery, lifting its stock more than 60%.

    By Dec. 9, 2019
  • Dive Awards

    Regulatory Development of the Year: 510(k) changes inch along

    New efforts by FDA to build out the program come years after the Institute of Medicine recommended scrapping it. More than 80% of devices are cleared through the pathway, so small changes can be meaningful to product safety.

    By David Lim • Dec. 9, 2019
  • Image attribution tooltip
    Kendall Davis / MedTech Dive
    Image attribution tooltip
    Dive Awards

    The MedTech Dive Awards of 2019

    From TAVR's takeoff to FDA's new approaches to premarket review, these are the industry forces that left their mark on medical technology this year.

    Dec. 9, 2019
  • EPA wants more data from ethylene oxide sterilizers, strikes device-friendly tone

    Administrator Andrew Wheeler said "medical device sterilization is vital to protecting public health" on release of a notice ahead of rulemaking that could impact sterilizers reliant on the carcinogenic gas.

    By David Lim • Dec. 6, 2019
  • Analysts cool expectations for Edwards' mitral performance

    Edwards execs told investors Thursday sales in the transcatheter mitral and tricuspid valve business should roughly double in 2020, but that's after a year when the unit's sales will likely fall short of initial targets.

    By Maria Rachal • Dec. 6, 2019
  • Establishment Labs' breast implant opportunity to triple: Jefferies

    The analysts predict entering China and the U.S. will open up markets worth close to $1 billion.  

    By Dec. 6, 2019
  • US healthcare spending growth rebounded last year, influenced by insurance tax

    Durable medical equipment annual growth jumped from 2.9% in 2017 to 4.7% in 2018.

    By Shannon Muchmore • Dec. 5, 2019
  • Edwards projects up to $5B in 2020 sales

    Across the aortic, mitral and tricuspid valve therapy markets Edwards Lifesciences targets, the company now expects worldwide opportunities to exceed $10 billion by 2024, per fresh estimates given to investors Thursday.

    By Maria Rachal • Dec. 5, 2019
  • FDA grades new Medtronic SynchroMed II recall as Class I event

    The voluntary move is the latest in a series of safety actions involving the implantable drug infusion pump, which was the focus of a 2015 consent decree between the company and the government.

    By Updated Dec. 10, 2019
  • Image attribution tooltip
    Jacob Bell / BioPharma Dive
    Image attribution tooltip

    Vicarious' surgical robot gets FDA breakthrough status

    The company also announced Scott Huennekens, former CEO of Google and Johnson & Johnson's robotic surgery joint venture, joined its board of directors.

    By Dec. 5, 2019
  • Boston Scientific afib device effective in reducing stroke

    Authors in the Journal of the American College of Cardiology said the rate of hemorrhagic stroke observed in left atrial appendage closure device registries is the lowest identified in the nonvalvular atrial fibrillation population.

    By Dec. 5, 2019
  • EU Parliament panel adopts MDR delay for some Class I devices, full nod likely

    One committee member called out the unusual nature of making late-in-the-game substantive regulatory changes through the corrigendum, a procedure typically meant for correcting technicalities and inconsistencies.

    By Dana Elfin • Dec. 4, 2019
  • FDA commissioner nominee backs 'proactive, not passive' approach to device safety

    While Stephen Hahn shed more light on his thoughts on certain medical device topics, he declined to say FDA scientific judgments of medical devices should be held to the same regulatory standards as drugs in response to a question. 

    By David Lim • Dec. 4, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Contract sterilizer of devices draws FDA warning over validation issues

    American Contract Systems received multiple complaints about the presence of foreign matter in sealed sterilization bags, the agency said.

    By Dec. 4, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Medtronic and Elekta form radiation therapy pacts with ViewRay

    ViewRay's plans to raise $75 million should help reduce concerns surrounding the company's liquidity, analysts at Jefferies said.

    By Dec. 3, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA seeks public input on pediatric device applications including ways to minimize burden

    The agency said it expects to receive about 47 original premarket approval, product development protocol or humanitarian device exemption submissions each year. About 11 submissions will lack required pediatric use information.

    By Dec. 2, 2019
  • Baxter closes $350M acquisition of Sanofi's Seprafilm adhesion barrier

    The company said it will immediately begin integrating the product, meant to reduce adhesion barriers in patients having abdominal or pelvic laparotomy procedures, into its advanced surgery business.

    By Maria Rachal • Updated Feb. 18, 2020
  • Image attribution tooltip
    Danielle Ternes
    Image attribution tooltip

    GE Healthcare bulks up in 3D printing, robotics, patient monitoring

    Projecting up to $20 billion in revenues this year, GE Healthcare is aiming to capitalize on the shift toward more precision in patient care with investments in Formlabs, CMR Surgical and Decisio Health.

    By Dec. 2, 2019
  • Dexcom server outage rocks Type 1 diabetes community

    The company announced late Monday it has restored services for its Dexcom Follow app to "near normal performance." Dexcom said it will work to improve communication methods with its customers.

    By David Lim • Updated Dec. 3, 2019
  • Intuitive gets FDA go-ahead for robotic system sealing instrument, power generator

    The devices add to the capabilities of Intuitive's da Vinci X and Xi as the robotic surgery giant works to grow recurring revenues and stave off competition.

    By Dec. 2, 2019
  • EU MDR delay for certain Class I devices moves forward: what it means for manufacturers

    "The Corrigendum will remove some pressure for these manufacturers" to obtain a CE Certificate of Conformity from a notified body, Fabien Roy and Elisabethann Wright of Hogan Lovells said.

    By Dana Elfin • Nov. 27, 2019
  • Roundup: How major medtechs fared in Q3

    A still robust economy, coupled with caution regarding a potential recession, is working in medtech's favor as the sector outperforms the S&P 500.

    By Maria Rachal • Nov. 27, 2019